Skip to main content
Quest Diagnostics

Whole Transcriptome RNA Sequencing to Identify Gene Fusions, Single Nucleotide Variants and Splicing Variants in Genes Associated with Somatic and Germline Malignancies

AMP 2023

Association for Molecular Pathology

Salt Lake City, UT, Nov 14-18 2023

Poster presentation: Whole Transcriptome RNA Sequencing to Identify Gene Fusions, Single Nucleotide Variants and Splicing Variants in Genes Associated with Somatic and Germline Malignancies

Authors: Liu Y, Williams N, Fuligni F, A. Gerasimova A, Elzinga C, Cdebaca V, Angeloni T, Russell M, Hambuch-Hawks T, Van Ness M, Ma C, Racke F, Godsey J

Specialty: Oncology, Genetics

Related content

Conference Presentation
Detection of Germline and Somatic BRCA Mutations Using a 50 Gene Next Generation Sequencing Panel
Conference Presentation
Incidental findings involving cancer susceptibility genes detected by germline chromosomal microarray
Conference Presentation
Utility of hereditary cancer panel testing in individuals with a known familial variant
Test FAQ
Solid Tumor Expanded Panel
Test FAQ
Guideline based Hereditary Cancer Panel
Audio Podcast
Optimize Oncology Care with Clinical Pathways

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.